Skin- and hair-related conditions, such as alopecia areata, pseudofolliculitis barbae, lichen planopilaris and severe seborrheic dermatitis, could also be to blame for facial hair changes ...
JAK inhibitors like baricitinib, ritlecitinib, and brepocitinib show promise in treating alopecia areata, with baricitinib approved by FDA and EMA. Baricitinib significantly reduced SALT scores at ...